本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ovid Therapeutics Inc.

0.5500
+0.070714.75%
盤後0.56000.0100+1.82%19:58 EDT
成交量:346.80萬
成交額:181.84萬
市值:3,911.02萬
市盈率:-1.60
高:0.5700
開:0.5300
低:0.4800
收:0.4793
資料載入中...
2023/05/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

重要事件披露

8-K - Current report
2023/05/01

重要事件披露

8-K - Current report
2023/04/27

重要事件披露

8-K - Current report
2023/03/13

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]